MENU
GKOS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Glaukos (GKOS) Ownership - Who owns Glaukos?
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
4.61B
P/E Ratio
N/A
Total Cash
295.43M
Projected Growth
N/A
Total Debt
383.74M
Revenue
314.71M
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash/Share
5.97
Total Debt/Equity
N/A
Revenue/Share
6.50 USD as % of share price
Fundamentals
GKOS
Capitalization
4.61B
P/E Ratio
N/A
Risk (Beta)
0.61
Dividend Yield
N/A
Total Cash
295M
Total Cash/Share
5.97
Total Debt
384M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.50%
Revenue
315M
ROE
N/A
Book Value
462M
P/B Ratio
9.97
Cash Flow
N/A
Earnings
-2.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
49K
Current Ratio
5.34
Current Revenue Per Employee
90810.37
Dividends Per Share - Security
N/A
EBITDA
-82.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
77.06
Revenue To Assets
-13.86
Shares Held By Institutions
8.06B
Shares Outstanding - Current
49.5M
Total Liabilities
479M
Total Volume MTD
N/A
Value
-1
Gain YTD
-33.280
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an ophthalmic medical device company
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com